News from johnson & johnson A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 12, 2022, 16:30 ET Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos...

May 11, 2022, 06:30 ET Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company

Johnson & Johnson (the "Company") (NYSE: JNJ) today announced the appointment of Thibaut Mongon as Chief Executive Officer Designate and Paul Ruh as...

May 02, 2022, 16:30 ET Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein 38th Annual Strategic Decisions Conference on Wednesday, June 1st, at the New York...

Apr 25, 2022, 07:30 ET Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance (AMR)

The new Center is focused on outpacing the rising threat of antimicrobial resistance (AMR) and builds on Johnson & Johnson's longstanding commitment...

Apr 20, 2022, 16:30 ET Johnson & Johnson to Participate in the UBS Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the UBS Global Healthcare Conference on Tuesday, May 24th. Mathai Mammen, Executive Vice President, ...

Apr 19, 2022, 06:25 ET Johnson & Johnson Reports Q1 2022 Results

Total sales growth of 5.0% to $23.4 Billion with operational growth of 7.7%* and adjusted operational growth of 7.9%* Earnings per share of $1.93...

Apr 19, 2022, 06:20 ET Johnson & Johnson Announces Dividend Increase of 6.6%

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 6.6% increase in the quarterly dividend, from $1.06 per...

Apr 07, 2022, 16:30 ET Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference

NEW BRUNSWICK, N.J., April 7, 2022 Johnson & Johnson (NYSE: JNJ) will participate in the BofA Securities 2022 Healthcare Conference at the Encore...

Mar 15, 2022, 08:20 ET Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 19th to review first-quarter...

Feb 15, 2022, 16:30 ET Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors

Johnson & Johnson (NYSE: JNJ) announced today that Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, has been appointed to its...

Feb 09, 2022, 16:28 ET Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Raymond James 43rd Annual Institutional Investors Conference on Tuesday, March 8th. Joseph J....

Feb 07, 2022, 16:51 ET Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 42nd Annual Health Care Virtual Conference on Monday, March 7th. Mathai Mammen, Executive ...

Jan 27, 2022, 17:28 ET Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive...

Jan 25, 2022, 06:25 ET Johnson & Johnson Reports Q4 and Full-Year 2021 Results

Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2021. "Our 2021 performance reflects continued strength across ...

Jan 06, 2022, 16:10 ET Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States

Johnson & Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the...

Jan 04, 2022, 08:00 ET Johnson & Johnson Announces Quarterly Dividend for First Quarter 2022

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2022 of $1.06 per...

Dec 30, 2021, 06:30 ET Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant

Johnson & Johnson (NYSE: JNJ) (the Company) today announced new preliminary results from the South African Phase 3b Sisonke study which showed that a ...

Dec 15, 2021, 08:32 ET Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

Dec 10, 2021, 13:39 ET Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, January 25th to review fourth-quarter ...

Dec 09, 2021, 17:00 ET World Health Organization Strategic Advisory Group of Experts (SAGE) Interim Recommendation Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the interim recommendation by the Strategic Advisory Group of Experts on Immunization...

Dec 09, 2021, 06:30 ET Johnson & Johnson Appoints Senior Leaders to Executive Committee

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the appointment of several senior leaders to the Company's Executive Committee....

Dec 05, 2021, 17:03 ET Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses

Johnson & Johnson (NYSE: JNJ) (the Company) today announced preliminary results from an independent study, including a subset of participants from...

Nov 12, 2021, 06:30 ET Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business

Johnson & Johnson (the "Company") (NYSE: JNJ) today announced its intent to separate the Company's Consumer Health business, creating a new publicly...

Nov 10, 2021, 17:14 ET Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World's Most Vulnerable People through Novel Humanitarian Buffer

Johnson & Johnson (NYSE: JNJ) (the Company) has entered into an agreement with the U.S. Government and Gavi, the Vaccine Alliance (Gavi), to enable...

Nov 09, 2021, 16:30 ET Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards

Johnson & Johnson (NYSE: JNJ) today announced that it has provided a $5MM endowment to Research!America to create an annual award to recognize...